Your product has pilot data and your team is credible. But investors keep asking questions you can't cleanly answer: What does your clinical evidence actually prove? Why should a health system trust this in live operations versus controlled conditions? You need those answers before the next meeting.
You're selling to health systems and your investor pitch isn't converting clinical buyers. Or your clinical pitch isn't landing with investors. These are different conversations requiring different evidence, different language, different sequence. Most founders are running one pitch for both.
You have a pitch deck full of claims. Before a sophisticated clinical buyer or investor runs the "show me" test on you in a live meeting, run it yourself. Not every claim survives. The ones that don't need to be reframed before they cost you a deal.
You're a technical or operational founder without a clinical co-founder. The product is built. The clinical credibility gap is showing up in conversations. You need someone who has been on the buyer side to tell you what they actually see.
Every core claim in your pitch deck or sales narrative gets run through the "show me" test. Two questions: can you demonstrate it in a live demo, or show pilot data that validates the outcome? Claims that fail get reframed before they fail in front of an investor or buyer.
Investor language and clinical buyer language are structurally different. We identify exactly which narrative you're using, which audience it's optimized for, and what it's missing for the other. You leave with both conversations mapped.
One clear constraint, one clear next action. Not a 40-slide deck. Not a 90-day plan you'll never execute. The one thing, if fixed, that changes the trajectory of your next meeting. That is what you leave with.
Client engagements, anonymized.
A founder came to refine their pitch deck. Before touching a single slide, we audited all 14 claims in it. Eleven were verifiable: demonstrable in a live demo or backed by pilot data. Three were roadmap items being presented as current capabilities.
Those three were reframed before they went in front of investors. The pitch got shorter. The founders stopped over-explaining features and started making an argument.
A founder was using one narrative for both investor meetings and health system demos. The investor pitch was strong. The health system demos were not converting.
The problem was not the product. It was the framing. Health system buyers are evaluating workflow fit, adoption risk, and clinical defensibility at the care model level. Investors are evaluating market size and exit potential. These require different evidence sets and different language.
Select a 90-minute slot via Calendly. You'll receive a short intake form asking for your pitch deck or sales narrative and two to three of the specific claims or objections you want to work through.
Send your materials 48 hours before the session. The session does not begin with introductions and background. It begins with the work. Come prepared to defend your claims.
90 minutes. No deck. A working document. You leave with: a clear read on which claims hold under clinical scrutiny, what the gap is between your investor narrative and your buyer narrative, and one concrete next move.
A written summary of the session findings arrives within 24 hours. If continued work is warranted, a proposal for the right engagement structure will be in that summary.
If your pitch is getting positive feedback but not moving forward, this is usually the next right step. 90 minutes. One clear answer on what to fix first.